0.35
-0.056(-13.79%)
Currency In USD
| Previous Close | 0.41 |
| Open | 0.4 |
| Day High | 0.41 |
| Day Low | 0.35 |
| 52-Week High | 2.44 |
| 52-Week Low | 0.22 |
| Volume | 1.79M |
| Average Volume | 6.41M |
| Market Cap | 14.54M |
| PE | -0.17 |
| EPS | -2.07 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 0.4 |
| Change | -0.06 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $212.12 as of October 24, 2025 at a share price of $0.35. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $104.79 as of October 24, 2025 at a share price of $0.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
GlobeNewswire Inc.
Oct 22, 2025 11:30 AM GMT
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
GlobeNewswire Inc.
Sep 23, 2025 12:00 PM GMT
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products co
ProPhase Continues its Exploration of a Crypto Treasury Strategy
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that the Company entered into an agreement relating to